CUSIP: 83578Q209
Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
2,295,708
-
Share change
-
+584,282
-
Total reported value
-
$6,448,511
-
Put/Call ratio
-
96%
-
Price per share
-
$2.81
-
Number of holders
-
29
-
Value change
-
+$1,863,172
-
Number of buys
-
12
-
Number of sells
-
13
Quarterly Holders Quick Answers
What is CUSIP 83578Q209?
CUSIP 83578Q209 identifies SPHS - SOPHIRIS BIO INC - COM NEW in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2018
-
Previous quarter:
Q1 2018
Recent filing periods for CUSIP 83578Q209:
Institutional Holders of SOPHIRIS BIO INC - COM NEW (SPHS) as of Q2 2018
As of 30 Jun 2018,
SOPHIRIS BIO INC - COM NEW (SPHS) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,295,708 shares.
The largest 10 holders included
VANGUARD GROUP INC, Palo Alto Investors LP, GEODE CAPITAL MANAGEMENT, LLC, JPMORGAN CHASE & CO, NORTHERN TRUST CORP, BlackRock Inc., Budros, Ruhlin & Roe, Inc., B & T Capital Management DBA Alpha Capital Management, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and Bank of New York Mellon Corp.
This page lists
29
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.